Evidence favouring PAF rather than leukotrienes in the pathogenesis of asthma
- PMID: 3774847
- DOI: 10.1016/0031-6989(86)90055-x
Evidence favouring PAF rather than leukotrienes in the pathogenesis of asthma
Similar articles
-
[The potential role and mechanism of leukotriene and platelet-activating factor in allergic disease].Nihon Rinsho. 1993 Mar;51(3):631-7. Nihon Rinsho. 1993. PMID: 8492436 Review. Japanese.
-
Relationship between LTC4 generation of hypodense eosinophils and bronchial hyperreactivity in asthmatic children.Int Arch Allergy Appl Immunol. 1990;92(1):82-7. doi: 10.1159/000235229. Int Arch Allergy Appl Immunol. 1990. PMID: 2246079
-
Role for platelet-activating factor in asthma.Lipids. 1991 Dec;26(12):1277-9. doi: 10.1007/BF02536547. Lipids. 1991. PMID: 1819715 Review.
-
Inflammatory mechanisms and nocturnal asthma.Am J Med. 1988 Jul 29;85(1B):64-70. doi: 10.1016/0002-9343(88)90245-8. Am J Med. 1988. PMID: 3041827 Review.
-
[Sulfidopeptide leukotrienes and asthma].Rev Mal Respir. 1989;6(6):483-91. Rev Mal Respir. 1989. PMID: 2557653 Review. French.
Cited by
-
Platelet activating factor and asthma.Agents Actions. 1986 Oct;19(1-2):100-8. doi: 10.1007/BF01977264. Agents Actions. 1986. PMID: 3099555 Review. No abstract available.
-
PAF induces rat plasma extravasation and releases eicosanoids during anaphylaxis.Inflammation. 1991 Oct;15(5):347-54. doi: 10.1007/BF00917351. Inflammation. 1991. PMID: 1757122
-
Prevention of non-specific airway hyperreactivity after allergen challenge in guinea-pigs by the PAF receptor antagonist SDZ 64-412.Br J Pharmacol. 1990 Feb;99(2):396-400. doi: 10.1111/j.1476-5381.1990.tb14715.x. Br J Pharmacol. 1990. PMID: 2328403 Free PMC article.